The stock of Inspiration Healthcare Group PLC (LON:IHC) is a huge mover today! The stock decreased 3.70% or GBX 2.5 on November 16, hitting GBX 65. Inspiration Healthcare Group PLC (LON:IHC) has risen 25.00% since April 19, 2016 and is uptrending. It has outperformed by 20.31% the S&P500.
The move comes after 6 months positive chart setup for the GBX 21.70 million company. It was reported on Nov, 16 by Barchart.com. We have GBX 152.10 PT which if reached, will make LON:IHC worth GBX 29.08 million more.
Inspiration Healthcare Group PLC (LON:IHC) Ratings Coverage
Out of 2 analysts covering Inspiration Healthcare Group (LON:IHC), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Inspiration Healthcare Group has been the topic of 3 analyst reports since November 18, 2015 according to StockzIntelligence Inc. WH Ireland maintained the stock with “Buy” rating in Wednesday, November 18 report. WH Ireland maintained Inspiration Healthcare Group PLC (LON:IHC) on Monday, February 22 with “Buy” rating.
More news for Inspiration Healthcare Group PLC (LON:IHC) were recently published by: Prnewswire.com, which released: “Global Market Study on Neonatal Infant Care Equipment: North America to Exceed …” on October 31, 2016. Digitaljournal.com‘s article titled: “Global Neonatal Infant Care Equipment Market Is Appraised to Be Valued US …” and published on November 15, 2016 is yet another important article.
Inspiration Healthcare Group plc, formerly Inditherm plc, is a supplier of medical devices mainly in areas of critical care. The company has a market cap of 21.70 million GBP. The Firm operates through four divisions: Critical Care, Operating Theatre, Home Healthcare, and Central and Unallocated costs. It has a 22.79 P/E ratio. Under the Critical Care segment, the Company’s products for premature and sick babies include LifeStart , Tecotherm Neo (for thermoregulation) and Inspire nCPAP (non-invasive respiratory support).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.